ES

Edward H. Schuchman

IS Icahn School Of Medicine At Mount Sinai: 14 patents #3 of 404Top 1%
GE Genzyme: 6 patents #103 of 891Top 15%
MM Mount Sinai School Of Medicine: 2 patents #18 of 151Top 15%
UP University of Pennsylvania: 1 patents #1,260 of 2,719Top 50%
UD Universität Duisburg-Essen: 1 patents #16 of 120Top 15%
SR Sloan Kettering Institute For Cancer Research: 1 patents #325 of 644Top 55%
📍 Haworth, NJ: #4 of 54 inventorsTop 8%
🗺 New Jersey: #3,327 of 69,400 inventorsTop 5%
Overall (All Time): #180,858 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
12023332 Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin Maria Dolores LEDESMA, Adrian BARTOLL 2024-07-02
10918702 Therapeutic acid ceramidase compositions and methods of making and using them 2021-02-16
10350277 Ceramidase and cell differentiation Calogera M. Simonaro 2019-07-16
10238721 Therapeutic acid ceramidase compositions and methods of making and using them 2019-03-26
10188705 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2019-01-29
10159724 Ceramide levels in the treatment and prevention of infections Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung 2018-12-25
9937246 Therapeutic acid ceramidase compositions and methods of making and using them 2018-04-10
9655953 Targeted protein replacement for the treatment of lysosomal storage disorders Silvia Muro Galindo, Vladimir R. Muzykantov 2017-05-23
9655954 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2017-05-23
9492514 Ceramide levels in the treatment and prevention of infections Erich Gulbins, Anthony Futerman, Yael Pewzner-Jung 2016-11-15
9155784 Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders Calogera M. Simonaro, Gary E. Striker, Helen Vlassara 2015-10-13
9114139 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2015-08-25
8961962 Acid ceramidase and mammalian cell survival Efrat Eliyahu, Nataly Shtraizent, Xingxuan He 2015-02-24
8889127 Targeted protein replacement for the treatment of lysosomal storage disorders Silvia Muro Galindo, Vladimir R. Muzykantov 2014-11-18
8709408 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2014-04-29
8658162 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2014-02-25
8349319 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency Robert J. Desnick, Gerald F. Cox, Laura P. Andrews, James Murray 2013-01-08
7750050 Chaperone-based therapy for Niemann-Pick disease Robert J. Desnick 2010-07-06
6790627 Methods and compositions for the modulation of acid-sphingomyelinase-related apoptosis Richard Kolesnick 2004-09-14
6541218 Acid sphingomyelinase protein and methods of treating type B Niemann-Pick disease Robert J. Desnick 2003-04-01
6274309 Method for the modulation of acid-sphingomyelinase-related apoptosis Richard Kolesnick 2001-08-14
5773278 Acid sphingomyelinase gene Robert J. Desnick 1998-06-30
5686240 Acid sphingomyelinase gene and diagnosis of Niemann-Pick disease Robert J. Desnick 1997-11-11